Salud financiera de hoja de balance de Nidan Laboratories and Healthcare
Salud financiera controles de criterios 5/6
Nidan Laboratories and Healthcare has a total shareholder equity of ₹662.1M and total debt of ₹124.3M, which brings its debt-to-equity ratio to 18.8%. Its total assets and total liabilities are ₹825.5M and ₹163.4M respectively. Nidan Laboratories and Healthcare's EBIT is ₹35.8M making its interest coverage ratio -6.4. It has cash and short-term investments of ₹28.5M.
Información clave
18.8%
Ratio deuda-patrimonio
₹124.35m
Deuda
| Ratio de cobertura de intereses | -6.4x |
| Efectivo | ₹28.50m |
| Patrimonio | ₹662.06m |
| Total pasivo | ₹163.45m |
| Activos totales | ₹825.51m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Análisis de la situación financiera
Pasivos a corto plazo: NIDAN's short term assets (₹302.8M) exceed its short term liabilities (₹113.2M).
Pasivo a largo plazo: NIDAN's short term assets (₹302.8M) exceed its long term liabilities (₹50.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: NIDAN's net debt to equity ratio (14.5%) is considered satisfactory.
Reducción de la deuda: NIDAN's debt to equity ratio has reduced from 311.9% to 18.8% over the past 5 years.
Cobertura de la deuda: NIDAN's operating cash flow is negative, therefore debt is not well covered.
Cobertura de intereses: NIDAN earns more interest than it pays, so coverage of interest payments is not a concern.